Celeste Frankenfeld Lamm, Ph.D., is currently a Director of Global Regulatory Affairs – CMC at Merck & Co, Inc. with 14 years of industry experience. In this capacity, she is responsible for regulatory strategy, engagement with regulatory authorities, and preparation of clinical CMC dossiers as well as marketing applications. In previous roles within the company, she led analytical development efforts to support both drug substance and formulation development, as well as a cross-functional team tasked with advancing a candidate from pre-clinical through clinical studies. Dr. Frankenfeld Lamm holds a B.A. in Chemistry and Biology from Greenville University, and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas.